English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Ethnopharmacology 2019-Sep

Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Han Zhou
Xingrong Peng
Tao Hou
Nan Zhao
Minghua Qiu
Xiuli Zhang
Xinmiao Liang

Keywords

Abstract

Located throughout the body, cannabinoid receptors (CB1 and CB2) play an important role in a variety of physiological processes and are therapeutic targets for obesity/metabolic diseases, neurological/mental disorders, pain management, and immune modulation. Phytocannabinoids are greatly important for the development of new medicines with high efficacy and/or minor side effects. Plants and fungi have been used in traditional medicine for their beneficial effects to mental and immune system. The current research studied five fungi from the same genus Ganoderma and five plants: Ganoderma hainanense J.D. Zhao, L.W. Hsu & X.Q. Zhang; Ganoderma capense (Lloyd) Teng, Zhong Guo De Zhen Jun; Ganoderma cochlear (Blume & T. Nees) Bres., Hedwigia; Ganoderma resinaceum Boud.; Ganoderma applanatum (Pers.) Pat.; Carthamus tinctorius L. (Compositae); Cynanchum otophyllum C. K. Schneid. (Asclepiadaceae); Coffea arabica L. (Rubiaceae); Prinsepia utilis Royle (Rosaceae); Lepidium meyenii Walp. (Brassicaceae). They have been used for immunoregulation, promotion of longevity and maintenance of vitality (such as species of Ganoderma), stimulant effects on the central nervous system (such as Coffea arabica L. (Rubiaceae)), hormone balance (such as Lepidium meyenii Walp. (Brassicaceae)) and other beneficial effects. However, it remains unclear whether the CB1 and CB2 receptors are involved in these effects.This work aimed to identify components working on CB1 and CB2 from the above plants and fungi, as novel phytocannabinoids, and to investigate mechanisms of how these compounds affected the cells. By analyzing the structure-activity relationship, we could identify the core structure for activity and synthesize more desirable molecules in future.Eighty-two naturally occurring compounds were screened on stably transfected Chinese hamster ovary (CHO) cell lines, CHO-CB1 and CHO-CB2, with application of a label-free dynamic mass redistribution (DMR) technology that measured cellular responses to compounds by a resonant waveguide grating optical biosensor. CP55,940 and WIN55,212-2 were used as agonist probe molecules, while SR141716A and SR144528 were antagonist probe molecules. Pertussis toxin, cholera toxin, LY294002 and U73122 were used as signaling pathway inhibitors. The DMR data were acquired by Epic Imager software (Corning, NY), processed by Imager Beta 3.7 (Corning), and analyzed by GraphPad Prism 6 (GraphPad Software, San Diego, CA).

RESULTS
Stably transfected CHO-CB1 and CHO-CB2 cell lines were established and characterized. Seven compounds induced responses/activities in the cells. Among the seven compounds, four were purified from two Ganoderma species with potencies between 20 to 35 μM. Three antagonists were identified: Kfb68 antagonized both receptors with a better desensitizing effect on CB2 to WIN55,212-2 over CP55,940. Kga1 and Kfb28 were antagonists selective to CB1 and CB2, respectively. Kfb77 was a special agonist and it stimulated CB1 in a mechanism different from that of CP55,940. Another three active compounds, derived from the Lepidium meyenii Walp. (Brassicaceae) plant, were also identified but their effects were mediated through mechanisms much related to the signaling transduction pathways, especially through the stimulatory Gs protein.

In this work, we identified four natural cannabinoids from two fungi: Ganoderma cochlear (Blume & T. Nees) Bres., Hedwigia and Ganoderma hainanense J.D. Zhao, L.W. Hsu & X.Q. Zhang. They exhibited structural and functional diversities. Our work confirms the presence of active ingredients in the Ganoderma species to CB1 and CB2, and this finding establishes connections between the fungi and the cannabinoid receptors, which will serve as a starting point to connect their beneficial effects to the endocannabinoid system. This research will also enrich the inventory of cannabinoids and phytocannabinoids from fungi. Yet due to some limitations of this work, further structure-activity relationship studies and mechanism investigation are warranted in future.

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge